[go: up one dir, main page]

AU2001269092A1 - Inhibitors of hepatitis b virus infection - Google Patents

Inhibitors of hepatitis b virus infection

Info

Publication number
AU2001269092A1
AU2001269092A1 AU2001269092A AU6909201A AU2001269092A1 AU 2001269092 A1 AU2001269092 A1 AU 2001269092A1 AU 2001269092 A AU2001269092 A AU 2001269092A AU 6909201 A AU6909201 A AU 6909201A AU 2001269092 A1 AU2001269092 A1 AU 2001269092A1
Authority
AU
Australia
Prior art keywords
hepatitis
inhibitors
virus infection
virus
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269092A
Inventor
Dorian Bevec
Sabine Obert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axxima Pharmaceuticals AG
Original Assignee
Axxima Pharmaceuticals AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axxima Pharmaceuticals AG filed Critical Axxima Pharmaceuticals AG
Publication of AU2001269092A1 publication Critical patent/AU2001269092A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001269092A 2000-06-27 2001-06-26 Inhibitors of hepatitis b virus infection Abandoned AU2001269092A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21455600P 2000-06-27 2000-06-27
US60/214,556 2000-06-27
PCT/EP2001/007260 WO2002000613A2 (en) 2000-06-27 2001-06-26 Inhibitors of hepatitis b virus infection

Publications (1)

Publication Number Publication Date
AU2001269092A1 true AU2001269092A1 (en) 2002-01-08

Family

ID=22799534

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269092A Abandoned AU2001269092A1 (en) 2000-06-27 2001-06-26 Inhibitors of hepatitis b virus infection

Country Status (2)

Country Link
AU (1) AU2001269092A1 (en)
WO (1) WO2002000613A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003006426A1 (en) * 2001-07-13 2003-01-23 Axxima Pharmaceuticals Ag Aromatic guanylhydrazones as effective compounds against neurodiseases
AU2002336746A1 (en) 2001-09-21 2003-04-01 Message Pharmaceuticals, Inc. Inhibitors of rnase p proteins as antibacterial compounds
SI1572095T1 (en) 2002-09-13 2015-12-31 Novartis Ag Beta-l-2'-deoxynucleosides for use in the treatment of resistant hbv strains
US7244765B2 (en) * 2004-06-25 2007-07-17 Cytokine Pharmasciences, Inc Guanylhydrazone salts, compositions, processes of making and methods of using
EP1778265B1 (en) 2004-08-17 2013-04-24 Ferring B.V. Guanylhydrazone compounds, compositions, methods of making and using
WO2006130697A1 (en) * 2005-06-01 2006-12-07 Cytokine Pharmasciences, Inc. Hmgb1 expression and protective role of semapimod in nec
EP2155675B1 (en) 2007-06-12 2014-02-19 Provid Pharmaceuticals, Inc. Kinase inhibitors, compositions thereof, and methods of use therewith
LT3505528T (en) 2011-04-21 2021-04-26 Glaxo Group Limited MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION
CN104918612B (en) * 2012-12-06 2019-10-25 巴鲁克斯布隆伯格研究所 Functionalized benzamide derivatives as antiviral agents against HBV infection
CN117482094A (en) * 2021-04-26 2024-02-02 北京慧宝源生物技术股份有限公司 Use of clevudine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB923398A (en) * 1960-08-09 1963-04-10 Vismara Francesco Spa Diphenyl mono-and bis-formyl guanylhydrazones
CH474486A (en) * 1965-11-19 1969-06-30 Ciba Geigy Process for the production of new diphenylureas
US5455863A (en) * 1993-06-29 1995-10-03 Motorola, Inc. Method and apparatus for efficient real-time authentication and encryption in a communication system
US5599984A (en) * 1994-01-21 1997-02-04 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions
ATE454141T1 (en) * 1996-11-15 2010-01-15 Cytokine Pharmasciences Inc GUANYLHYDRAZONES WHICH ARE USEFUL FOR TREATING T-CELL RELATED DISEASES
US6319894B1 (en) * 1997-01-08 2001-11-20 The Picower Institute For Medical Research Complexes and combinations of fetuin with therapeutic agents
WO2001025192A1 (en) * 1999-10-06 2001-04-12 Melacure Therapeutics Ab Guanidine derivatives and their use in the production of a medicament for blocking xanthine oxidase/dehydrogenase
AU2001240578A1 (en) * 2000-02-02 2001-08-14 Axxima Pharmaceuticals Ag Pharmaceutically active aromatic guanylhydrazones
GB0019357D0 (en) * 2000-08-07 2000-09-27 Melacure Therapeutics Ab Novel phenyl guanidines

Also Published As

Publication number Publication date
WO2002000613A2 (en) 2002-01-03
WO2002000613A3 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
AU2002230763A1 (en) Inhibitors of hepatitis c virus ns3 protease
AU2001245356A1 (en) Inhibitors of hepatitis c virus ns3 protease
AU2055301A (en) Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease
AU2001282922A1 (en) Novel imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus
AU2002230764A1 (en) Imidazolidinones and their related derivatives as hepatitis c virus ns3 protease inhibitors
AU2001277967A1 (en) Peptides as ns3-serine protease inhibitors of hepatitis c virus
AU6371900A (en) Lactam inhibitors of hepatitis c virus ns3 protease
EP1292603B8 (en) Methods and compositions for treating hepatitis c virus
AP2001002301A0 (en) Inhibition of viral infection using monovalentantigen-binding proteins
AU2002210450A1 (en) Maintaining virus detection software
HU229997B1 (en) Peptides as ns3-serine protease inhibitors of hepatitis c virus
AU2001282528A1 (en) Compounds having anti-hepatitis c virus effect
AU9092501A (en) Compositions and methods for inhibition of hiv-1 infection
EP1252325A4 (en) Compositions and methods for inhibition of hiv-1 infection
AU2002343556A1 (en) Use of phosphonate nucleotide analogue for treating hepatitis b virus infections
AU1167602A (en) Methods of therapy for hiv infection
AU2002346686A1 (en) Compositions and method for treating hepatitis virus infection
AU2003216523A1 (en) Treatment of pre-core hepatitis b virus mutant infections
AU2001296864A1 (en) Detection of varicella-zoster virus
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2001269092A1 (en) Inhibitors of hepatitis b virus infection
AU2003294757A1 (en) Formulations useful against hepatitis c virus infections
AU2281601A (en) Treatment of viral infections using levovirinTM
AU2001292947A1 (en) Methods for inhibition of viral infection
AU2002243257A1 (en) Oncolytic virus